About Sebastian Unizony, MD
Dr Unizony is the director of the Rheumatology Vasculitis Program. His main academic interests include the use of clinical and translational research methods to advance the treatment for patients with systemic vasculitides and related disorders, including giant cell arteritis, polymyalgia rheumatica and ANCA-associated vasculitis. He is a member of the Pan American League of Associations for Rheumatology (PANLAR) vasculitis group that has published treatment guidelines for giant cell arteritis, Takayasu’s arteritis and ANCA-associated vasculitis. A list of his publications can be found in the following link:
Clinical Interests:
- ANCA-associated vasculitis
- Aortitis
- Behcet's syndrome
- Cryoglobulinemia
- Dermatomyositis
- Giant cell arteritis
- Lupus
- Rheumatoid arthritis
Treats:
- Adult
Languages:
- Spanish
Locations
Mass General Rheumatology
55 Fruit St.
Yawkey Center for Outpatient Care
Suite 4B
Boston, MA 02114
Phone: 617-726-7938
Medical Education
- MD, Universidad Nacional de La Plata
- Residency, Hospital Carlos Durand
- Residency, St. Luke's Roosevelt Hospital Center
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Rheumatology, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
Matza MA, Arevalo AB, Unizony S. Imaging Challenges and Developments in Large-vessel Vasculitis. Rheum Dis Clin North Am. 2024, PMID: 39415370
Magri SJ, Ugarte-Gil MF, Brance ML, Flores-Su?rez LF, Fern?ndez-?vila DG, Scolnik M, Sato EI, de Souza AWS, Saldarriaga-Rivera LM, Babini AM, Zamora NV, Felquer MLA, Vergara F, Carlevaris L, Scarafia S, Guppy ERS, Unizony S; Pan American League of Associations for Rheumatology. Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis. Lancet Rheumatol. 2023 PMID: 38251580
Unizony S, Matza MA, Jarvie A, O'Dea D, Fernandes AD, Stone JH. Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study. Lancet Rheumatol. 2023, PMID: 38251564
Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med. 2023, PMID: 37792612 Clinical Trial.
Matza MA, Dagincourt N, Mohan SV, Pavlov A, Han J, Stone JH, Unizony S. Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis. RMD Open. 2023, PMID: 37024237
Scolnik M, Brance ML, Fern?ndez-?vila DG, Inoue Sato E, de Souza AWS, Magri SJ, Saldarriaga-Rivera LM, Ugarte-Gil MF, Flores-Suarez LF, Babini A, Zamora NV, Acosta Felquer ML, Vergara F, Carlevaris L, Scarafia S, Soriano Guppy ER, Unizony S; Pan American League of Associations for Rheumatology (PANLAR). Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis. Lancet Rheumatol. 2022, PMID: 38261393
Cid MC*, Unizony S*, Blockmans D, Brouwer E, Dagna L, Dasgupta B, Hellmich B, Molloy E, Salvarani C, Trapnell BC, Warrington KJ, Wicks I, Samant M, Zhou T, Pupim L, Paolini JF; KPL-301-C001 Investigators. Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2022, PMID: 35264321. * Co-first authors
Unizony S, Bao M, Han J, Luder Y, Pavlov A, Stone JH. Treatment failure in giant cell arteritis. Ann Rheum Dis. 2021, PMID: 34049857
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony S, Collinson N. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med. 2017, PMID: 28745999
Dr Unizony is the best. He knows me, my history, remembers my issues. He is friendly and professional. I've been seeing him for 11 years, wouldn't see anyone else. Plus, a sense of humor!
Dr. Unizony is tops in his field for the disease I have. We talked about clinical trials and I was able to get a ether understanding about my situation
Excellent! Only concern, this was a consult for my regular rheumatologist. I do not see a write up or report for this visit. My Rheumatologist has not recieved any reoprt or write up. This info is needed.
Nothing short of amazing for the last 13 yrs
Yes, Dr. Unizony has always been extraordinarily thoughtful and informative and has taken care of me for the last two, three years I believe. And at all times he has been amazingly kind and full of information and has done all sorts of different tests. I couldn't recommend him more highly.
Excellent provider. A fellow or resident first came in, but I told him I only wanted to deal with Dr. Unizony. That day i was definitely not in the mood to go through a lengthy assessment.
Excellent. I have seen Dr. Unizony for years and he is always helpful, responsive and knowledgable.
Thought it was a good visit
Immediately after being diagnosed with Giant Cell Arteritis (GCA) in [redacted], I sought out Dr. Unizony, a leading researcher for treatment of GCA, for my treatment. I was quickly accepted into a clinical trial he was leading to test a new GCA treatment and received incredible attention and care. When my 12 months in the trial ended, Dr. Unizony ... Read More
Excellent